I thought the statements were clear, accurate and measured.
Trials haven't started, drug formulations are being refined, no ethics approval or recruitment as yet.
No major holder updates is pretty clear.
There will be dilution if oppies are converted (we'll also get big cash injection)
Most importantly - Have patience, and don't over antcipate. This will need some time before it blooms - I'd agree...
Any who, nice start to the year, seen a really nice bounce, lets hope it continues..
- Forums
- ASX - By Stock
- IHL
- Share your ideas and thoughts.
Share your ideas and thoughts., page-314
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online